Option Care Health (OPCH) issues Q1 2026 results, trims revenue outlook
Rhea-AI Filing Summary
Option Care Health reported mixed first quarter 2026 results, with net revenue of $1,350.7 million, up 1.3% year over year. GAAP net income was $45.3 million, down 3.0%, while GAAP diluted EPS rose to $0.29 and Adjusted diluted EPS held flat at $0.40.
Adjusted EBITDA was $104.8 million, down 6.3%, and operating activities used $12.1 million of cash. The company repurchased $17.5 million of stock and expanded its revolving credit facility from $400 million to $850 million, adding financial flexibility.
For full year 2026, Option Care Health now guides to net revenue of $5.675–$5.775 billion, Adjusted EBITDA of $480–$505 million, Adjusted diluted EPS of $1.82–$1.92, and at least $320 million of cash provided by operating activities, reflecting modest growth expectations.
Positive
- None.
Negative
- None.
Insights
Q1 2026 shows modest growth, margin pressure, guidance intact.
Option Care Health delivered Q1 2026 net revenue of $1,350.7M, up 1.3%, but Adjusted EBITDA fell 6.3% to $104.8M as costs and mix offset topline gains. GAAP net income slipped to $45.3M, though diluted EPS improved to $0.29 due to share count changes.
Cash flow from operations was negative $12.1M in the quarter, consistent with the company’s description of seasonal patterns. Management also repurchased $17.5M of stock and expanded the revolving credit facility from $400M to $850M, which could support liquidity and future initiatives.
For full year 2026, guidance calls for net revenue of $5.675B–$5.775B (about 1% growth vs. 2025), Adjusted EBITDA of $480M–$505M, and Adjusted diluted EPS of $1.82–$1.92. The company highlights a significant headwind from its chronic inflammatory disease portfolio and emphasizes “decisive actions” to reaccelerate growth, with more detail likely emerging in subsequent filings and earnings updates.
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
revolving credit facility financial
cash used in operating activities financial
stock-based compensation expense financial
forward-looking statements regulatory
Earnings Snapshot
For full year 2026, the company expects net revenue of $5.675–$5.775B, Adjusted EBITDA of $480–$505M, Adjusted diluted EPS of $1.82–$1.92, and at least $320M of cash from operating activities.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) |
(IRS Employer Identification Number) |
| (Address of principal executive offices) |
(
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol(s) | Name of each exchange on which registered | ||
Item 2.02. Results of Operations and Financial Condition.
On April 30, 2026, Option Care Health, Inc. (the “Company”) issued a press release reporting its first quarter 2026 financial results. A copy of the press release is furnished with this Form 8-K and attached hereto as Exhibit 99.1.
The press release and presentation include certain non-GAAP financial measures described therein. Reconciliation between any non-GAAP financial measures presented and the most directly comparable GAAP financial measures is also provided.
Item 7.01. Regulation FD Disclosure.
To supplement the information in the attached press release, the Company has also prepared a presentation, which will be available on the Company’s website at https://investors.optioncarehealth.com/events-and-presentations/presentations and is attached hereto as Exhibit 99.2 to this Current Report on Form 8-K.
The information in this Form 8-K and the Exhibits attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | |
| 99.1 | Press release dated April 30, 2026 | |
| 99.2 | Option Care Health Presentation dated April 30, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Option Care Health, Inc. | ||
| Date: April 30, 2026 | By: | /s/ Meenal Sethna |
| Meenal Sethna | ||
| Chief Financial Officer |
Exhibit 99.1
OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026
BANNOCKBURN, IL., April 30, 2026 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2026.
First Quarter 2026 Financial Highlights
(year-over-year comparisons unless otherwise noted)
| · | Net revenue of $1,350.7 million, up 1.3% | |
| · | GAAP Net income of $45.3 million, down 3.0% | |
| · | GAAP diluted earnings per share of $0.29, up 3.6% | |
| · | Adjusted EBITDA of $104.8 million, down 6.3% | |
| · | Adjusted diluted earnings per share of $0.40, flat to the first quarter of 2025 | |
| · | Cash used in operating activities of $12.1 million | |
| · | Repurchased $17.5 million of stock in the quarter | |
| · | Revolving credit facility expanded from $400 million to $850 million |
“The first quarter reflected a mixed performance for our business, and we are not satisfied with our revenue growth momentum,” commented John C. Rademacher, President & Chief Executive Officer, Option Care Health. “Our team continues to provide high-quality care for patients and deepen relationships with key stakeholders and our foundation remains strong. We are an execution-driven organization and are taking decisive actions to re-accelerate our growth trajectory and position us for greater long-term value creation.”
Updated Full Year 2026 Financial Guidance
For the full year 2026, Option Care Health now expects to generate:
| · | Net revenue of $5.675 billion to $5.775 billion | |
| · | Adjusted diluted earnings per share of $1.82 to $1.92 | |
| · | Adjusted EBITDA of $480 million to $505 million | |
| · | Cash provided by operating activities of at least $320 million |
Conference Call
Option Care Health will host a conference call to discuss its results on Thursday, April 30, 2026, at 8:30 a.m. ET. The conference call can be accessed via a live audio webcast that will be available online at investors.optioncarehealth.com. A replay of the call will be available at the same web link for 90 days after the call.
About Option Care Health
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members, including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.
Investor Contact
Nicole Maggio
Senior Vice President, Corporate Controller
investor.relations@optioncare.com
Forward-Looking Statements - Safe Harbor
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements the Company may make regarding future revenues, future earnings, other future financial results, regulatory developments, market developments, new products and growth strategies and the effects of any of the foregoing on its future results of operations or financial condition.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: changes in laws, regulations or trade policies applicable to its business model; loss of relationships with managed care organizations and other non-governmental third party payers; changes in the pharmaceutical industry, including limiting or discontinuing research, development, production and marketing of pharmaceuticals compatible with its services; changes in market conditions and receptivity to its services and offerings; and pending and future litigation or potential liability for claims not covered by insurance. For a detailed discussion of the risk factors that could affect its actual results, please refer to the risk factors identified in the Company's SEC reports as filed with the SEC.
Any forward-looking statement made by the Company in this press release is based only on information currently available to it and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Note Regarding Use of Non-GAAP Financial Measures
In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted net income, Adjusted EBITDA and Adjusted diluted earnings per share ("EPS"), which are non-GAAP financial measures. These adjusted measures are not measurements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, EPS, or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company’s liquidity. In addition, the Company's definitions of Adjusted net income, Adjusted EBITDA, and Adjusted diluted EPS may not be comparable to similarly titled non-GAAP financial measures reported by other companies. As defined by the Company: (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted diluted EPS represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long-lived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of Option Care Health’s business operations and facilitate comparisons to the Company’s historical operating results. The Company has not reconciled Adjusted EBITDA guidance to net income or Adjusted diluted EPS guidance to GAAP diluted EPS as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each historical adjusted measure to the most comparable GAAP financial measure are set forth below.
| Schedule 1 | |||||||||||
| OPTION CARE HEALTH, INC. | |||||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||
| (IN THOUSANDS)(UNAUDITED) | |||||||||||
| March 31, 2026 | December 31, 2025 | |||||||
| ASSETS | ||||||||
| CURRENT ASSETS: | ||||||||
| Cash and cash equivalents | $ | 177,321 | $ | 232,624 | ||||
| Accounts receivable, net | 516,436 | 473,566 | ||||||
| Inventories | 415,686 | 471,149 | ||||||
| Prepaid expenses and other current assets | 85,664 | 87,629 | ||||||
| Total current assets | 1,195,107 | 1,264,968 | ||||||
| NONCURRENT ASSETS: | ||||||||
| Property and equipment, net | 139,939 | 139,236 | ||||||
| Intangible assets, net | 21,063 | 21,897 | ||||||
| Referral sources, net | 278,845 | 287,281 | ||||||
| Goodwill | 1,606,743 | 1,606,743 | ||||||
| Other noncurrent assets | 138,403 | 135,644 | ||||||
| Total noncurrent assets | 2,184,993 | 2,190,801 | ||||||
| TOTAL ASSETS | $ | 3,380,100 | $ | 3,455,769 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| CURRENT LIABILITIES: | ||||||||
| Accounts payable | $ | 545,016 | $ | 639,829 | ||||
| Other current liabilities | 184,729 | 189,519 | ||||||
| Total current liabilities | 729,745 | 829,348 | ||||||
| NONCURRENT LIABILITIES: | ||||||||
| Long-term debt, net of discount, deferred financing costs and current portion | 1,153,040 | 1,154,052 | ||||||
| Other noncurrent liabilities | 146,246 | 145,976 | ||||||
| Total noncurrent liabilities | 1,299,286 | 1,300,028 | ||||||
| Total liabilities | 2,029,031 | 2,129,376 | ||||||
| STOCKHOLDERS’ EQUITY | 1,351,069 | 1,326,393 | ||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 3,380,100 | $ | 3,455,769 | ||||
| Schedule 2 | |
| OPTION CARE HEALTH, INC. | |
| CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS | |
| (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED) |
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| NET REVENUE | $ | 1,350,654 | $ | 1,332,972 | ||||
| COST OF REVENUE | 1,088,640 | 1,069,920 | ||||||
| GROSS PROFIT | 262,014 | 263,052 | ||||||
| OPERATING COSTS AND EXPENSES: | ||||||||
| Selling, general and administrative expenses | 169,955 | 162,808 | ||||||
| Restructuring, acquisition and integration costs | 4,607 | 5,310 | ||||||
| Depreciation and amortization expense | 14,907 | 15,746 | ||||||
| Total operating expenses | 189,469 | 183,864 | ||||||
| OPERATING INCOME | 72,545 | 79,188 | ||||||
| OTHER INCOME (EXPENSE): | ||||||||
| Interest expense, net | (13,304 | ) | (13,231 | ) | ||||
| Other, net | 1,762 | (2,401 | ) | |||||
| Total other (expense) income | (11,542 | ) | (15,632 | ) | ||||
| INCOME BEFORE INCOME TAXES | 61,003 | 63,556 | ||||||
| INCOME TAX EXPENSE | 15,660 | 16,814 | ||||||
| NET INCOME | $ | 45,343 | $ | 46,742 | ||||
| Earnings per share, basic | $ | 0.29 | $ | 0.28 | ||||
| Earnings per share, diluted | $ | 0.29 | $ | 0.28 | ||||
| Weighted average common shares outstanding, basic | 156,653 | 165,460 | ||||||
| Weighted average common shares outstanding, diluted | 158,209 | 166,804 | ||||||
| Schedule 3 | |
| OPTION CARE HEALTH, INC. | |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |
| (IN THOUSANDS)(UNAUDITED) |
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
| Net income | $ | 45,343 | $ | 46,742 | ||||
| Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
| Depreciation and amortization expense | 15,655 | 16,373 | ||||||
| Other adjustments | 16,625 | 17,642 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable, net | (42,870 | ) | (56,788 | ) | ||||
| Inventories | 55,463 | 21,790 | ||||||
| Prepaid expenses and other current assets | 1,233 | 28,444 | ||||||
| Accounts payable | (93,246 | ) | (88,101 | ) | ||||
| Accrued compensation and employee benefits | (20,982 | ) | (14,458 | ) | ||||
| Other | 10,669 | 21,142 | ||||||
| Net cash used in operating activities | (12,110 | ) | (7,214 | ) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
| Acquisition of property and equipment | (9,046 | ) | (9,371 | ) | ||||
| Business acquisitions, net of cash acquired | — | (117,322 | ) | |||||
| Other investing activities | (274 | ) | — | |||||
| Net cash used in investing activities | (9,320 | ) | (126,693 | ) | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
| Purchase of company stock and related excise taxes | (17,539 | ) | (100,222 | ) | ||||
| Other financing activities | (16,334 | ) | (7,064 | ) | ||||
| Net cash used in financing activities | (33,873 | ) | (107,286 | ) | ||||
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | (55,303 | ) | (241,193 | ) | ||||
| Cash and cash equivalents - beginning of period | 232,624 | 412,565 | ||||||
| CASH AND CASH EQUIVALENTS - END OF PERIOD | $ | 177,321 | $ | 171,372 | ||||
| Schedule 4 | |
| OPTION CARE HEALTH, INC. | |
| QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES | |
| (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED) |
| Three Months Ended March 31, | ||||||||
| 2026 | 2025 | |||||||
| Net income | $ | 45,343 | $ | 46,742 | ||||
| Interest expense, net | 13,304 | 13,231 | ||||||
| Income tax expense | 15,660 | 16,814 | ||||||
| Depreciation and amortization expense | 15,655 | 16,373 | ||||||
| EBITDA | 89,962 | 93,160 | ||||||
| EBITDA adjustments | ||||||||
| Stock-based incentive compensation expense | 10,199 | 8,801 | ||||||
| Restructuring, acquisition, integration and other (1) | 4,609 | 9,806 | ||||||
| Adjusted EBITDA | $ | 104,770 | $ | 111,767 | ||||
| Net income | $ | 45,343 | $ | 46,742 | ||||
| Intangible asset amortization expense | 9,270 | 9,097 | ||||||
| Stock-based incentive compensation expense | 10,199 | 8,801 | ||||||
| Restructuring, acquisition, integration and other (1) | 4,609 | 9,806 | ||||||
| Total pre-tax adjustments | 24,078 | 27,704 | ||||||
| Tax adjustments (2) | (6,188 | ) | (7,342 | ) | ||||
| Adjusted net income | $ | 63,233 | $ | 67,104 | ||||
| Earnings per share, diluted | $ | 0.29 | $ | 0.28 | ||||
| Adjusted earnings per share, diluted | $ | 0.40 | $ | 0.40 | ||||
| Weighted average common shares outstanding, diluted | 158,209 | 166,804 | ||||||
(1) Restructuring, acquisition, integration and other includes $4,607 and $5,310 of operating expenses for the three months ended March 31, 2026 and 2025, respectively.
(2) Tax adjustments for the three months ended March 31, 2026 and 2025 includes the estimated income tax effect on non-GAAP adjustments based on the effective tax rate.
Exhibit 99.2
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Extraordinary Care That Changes Lives Option Care Health, Inc. Q1 2026 Earnings Call April 30, 2026 1
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Forward - Looking Statements This presentation may contain “forward - looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward - looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “shoul d,” “will” and similar references to future periods. Examples of forward - looking statements include, among others, statements we may make regarding future revenues, future earnings, other future financial r esu lts, regulatory developments, market developments, new products and growth strategies, and the effects of any of the foregoing on our future results of operations or financial conditions. Forward - looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on ou r current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future condition s. Because forward - looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward - looking statements. Importa nt factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: changes in laws, regulations or trade policies applicable to our business model; loss of relationships with managed care organizations and other non - governmental third party payers; changes in the pharmaceutical indus try, including limiting or discontinuing research, development, production and marketing of pharmaceuticals compatible with our services; changes in market conditions and receptivity to our se rvices and offerings; and pending and future litigation or potential liability for claims not covered by insurance. For a detailed discussion of the risk factors that could affect our actual res ult s, please refer to the risk factors identified in our reports as filed with the SEC. Any forward - looking statement made by us in this presentation is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward - looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. Non - GAAP Measures In addition to reporting financial information in accordance with generally accepted accounting principles (“GAAP”), we are a lso reporting Adjusted net income, Adjusted EBITDA, and Adjusted diluted earnings per share ("Adjusted diluted EPS"), each of which are non - GAAP financial measures. These adjusted measures are not meas urements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, net profit margin, earnings per share or any other perform anc e measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of our liquidity. In addition, our definitions of Adjusted ne t i ncome, Adjusted EBITDA, and Adjusted diluted EPS may not be comparable to similarly titled non - GAAP financial measures reported by other companies. As defined by us: ( i ) Adjusted net income represents net income before intangible asset amortization expense, stock - based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, net of tax adjustments; ( ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock - based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses ; and (iii) Adjusted diluted EPS represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part o f r estructuring, acquisition, integration and other expenses, we may incur significant charges such as the write down of certain long - lived assets, temporary redundant expenses, pr ofessional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for cert ain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of our business operations and facilitate co mparisons to our historical operating results. We have not reconciled Adjusted EBITDA and Adjusted diluted EPS guidance to net income as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each historical adjusted measure to the most comparable G AAP financial measure are set forth at the end of this presentation. 2 Q1 '26 Earnings Call Presentation | April 30, 2026
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED o Mixed Q1 results o Strong execution across Acute o Transitional period for Chronic o Continued focus on strategic initiatives o Full - year 2026 guidance o Adjusting Net Revenue guidance and Cash Flow from Operations target o Maintaining Adj. EBITDA and Adj. Diluted EPS guidance o Taking decisive actions to reaccelerate revenue growth trajectory and drive greater long - term value creation Q1 RESULTS & FULL - YEAR 2026 UPDATE Q1 '26 Earnings Call Presentation | April 30, 2026 3
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 4 Q1 2026 FINANCIAL PERFORMANCE Growth Highlights vs. PY o Revenue +1% o Acute: High single digit growth o Chronic: Slight decline o IG/neuro portfolio solid growth o Offset by chronic inflammatory portfolio (CID) decline and certain other specialty therapies o EBITDA ( - 6%) o Strong Acute performance and strategic initiatives offset by CID headwind o Adj. Diluted EPS flat o +$0.02 YoY benefit from share repurchases o Q1 Operating Cash Flow ( - $12M) o Consistent with seasonal patterns $105 $112 Adj. EBITDA $ $0.29 $0.28 GAAP Diluted EPS $0.40 $0.40 Adj. Diluted EPS $1,333 $1,351 Q1 - 25 Q1 - 26 Revenue ($ in millions except EPS) Q1 '26 Earnings Call Presentation | April 30, 2026
FY ’26 Guidance Update + Growth vs. PY 1 © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 5 Guidance Key Assumptions FULL - YEAR 2026 GUIDANCE & KEY ASSUMPTIONS o FY ’26 o Approx. ( - 600bps) total company Net Revenue growth headwind from CID o Approx. ( - $55M) GP$ headwind from CID, to be realized evenly over the year o Effective tax rate 26% - 28% o Net interest expense $50M - $55M o Q2 ’26 sequential growth assumptions vs. Q1 ’26 o Net Revenue: +Mid - single digits o Adj. EBITDA: +High - single digits o Net Revenue $5.675B to $5.775B, +1% o Adj. Diluted EPS $1.82 to $1.92, +9% o Adj. EBITDA $480M to $505M, +5% o Cash Flow from Operations of at least $320M 1 Growth represents ’26 midpoint of guidance compared to 2025 results Q1 '26 Earnings Call Presentation | April 30, 2026
Contact Us Our Website © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED investors@optioncarehealth.com optioncarehealth.com 6 Q1 '26 Earnings Call Presentation | April 30, 2026
© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Reconciliation to Non - GAAP Measures For historical reconciliations of non - GAAP financial measures, please see our SEC filings and other financial reports, which are available on our website at investors.optioncarehealth.com 7 Q1 '26 Earnings Call Presentation | April 30, 2026